# Chronus Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chronus-health

- Industry: Medical Devices & Equipment
- Headquarters: Mountain View, US
- Website: www.chronushealth.com
- Total disclosed funding: $24M
- Latest round: Series A (Sep 16, 2021)
- Investors on record: 5

## About

Chronus Health, Inc. is a technology company that develops innovative software solutions aimed at enhancing operational efficiency and decision-making across various industries.Founded in 2017, Chronus Health, Inc. is based in Mountain View, US. The company specializes in advanced software solutions that address inefficiencies in workflows and data management. The founders, Anand Parikh and Ashish Jagtiani, have a history of entrepreneurship contributing to the company’s strategic direction. In September 2021, Chronus Health raised USD 22.09 mn in a Series A funding round led by Tarsadia Investments, with participation from Monta Vista Capital, Savantus Ventures, and returning investor SOSV. The total amount raised to date stands at USD 22.09 mn.Chronus Health specializes in delivering innovative solutions tailored to meet the needs of various industries. Their core product offerings include advanced software platforms and integrated systems designed to streamline operations, enhance productivity, and facilitate effective decision-making processes. These products address challenges such as inefficient workflows and data management, primarily serving enterprises in finance, healthcare, and technology sectors, with users ranging from operational teams to executive management. Their products are strategically marketed across North America, Europe, and parts of Asia to leverage regional demands.Chronus Health’s revenue model combines subscription-based services with direct sales of proprietary software solutions. Clients enter into annual or multi-year subscription agreements, ensuring access to software updates, support, and training. The company offers tiered pricing plans to accommodate various business sizes, which fosters flexibility for both small enterprises and large corporations. These arrangements enable seamless transactions as businesses incorporate their software into operations, establishing dependency on Chronus Health’s offerings for critical functions and driving long-term client relationships.Chronus Health plans to utilize the USD 22.09 mn raised in Series A funding to scale its research, engineering, and data science teams while accelerating product and technology development. The company is focused on launching new products designed to enhance client engagement and operational capabilities. Additionally, it aims to expand into new geographic regions, specifically targeting markets in Asia and Europe by the end of 2023.

## Funding rounds

- Series A, Sep 16, 2021, $22M — SOSV, Tarsadia Investments, Monta Vista Capital, Savantus Ventures
- Seed, Jan 15, 2020 — SOSV, IndieBio
- Seed, Apr 29, 2019, $1.3M — SOSV
- Seed, Jul 6, 2018, $0.5M — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed, Series A
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed
- Tarsadia Investments — Series A
- Monta Vista Capital (https://capitalatlas.ai/funds/monta-vista-capital) — Series A
- Savantus Ventures (https://capitalatlas.ai/funds/savantus-ventures) — Series A